Direct-Acting Antivirals Are a Milestone for Hepatitis C Virus Infection? Analysis of 15 Years of Patient and Diagnosis Data from a Region in Türkiye

: The introduction of DAAs in 2016 marked a milestone, leading to a nearly 90% reduction in the viremic patient burden in our region. The steady aging of the HCV-positive population suggests that the infected pool is shrinking and is not replenished. However, global and regional crises can hinder screening efforts, necessitating resilient public health strategies to achieve World Health Organization 2030 elimination targets.